Quarterly Report • May 18, 2022
Quarterly Report
Open in ViewerOpens in native device viewer

| Q1 2022 | Change | Q1 2021 | 2021 |
|---|---|---|---|
| 277.0 | –14.2% | 323.1 | 1,182.2 |
| 36.5 | –70.1% | 122.2 | 361.8 |
| 13.2% | –24.6 PP | 37.8% | 30.6% |
| 23.7 | –78.6% | 110.8 | 315.0 |
| 8.6% | –25.7 PP | 34.3% | 26.6% |
| 15.5 | –81.8% | 85.5 | 247.5 |
| 0.75 | –81.8% | 4.13 | 11.99 |
| 29.6 | –0.75 | 118.7 | 323.4 |
| 11.1% | –87% | 86.2% | 45.7% |
| in EUR million | 31.03.2022 | Change | 31.3.2021 | 31.12.2021 |
|---|---|---|---|---|
| Total assets | 996.7 | 15.2% | 865.3 | 958.6 |
| Equity | 560.4 | 41.5% | 396.1 | 540.1 |
| Equity ratio | 56.2% | +10.4 PP | 45.8% | 56.3% |
| Additions to intangible assets and property, plant and equipment | ||||
| 10.0 | –17.9% | 12.2 | 56.4 | |
| Employees (at reporting date) | 7,007 | 0.1% | 7,001 | 6,948 |
| in EUR million | Q1 2022 | Change | Q1 2021 | 2021 |
|---|---|---|---|---|
| Industrial Sector = Semperflex + Sempertrans + Semperform + Semperseal | ||||
| Revenue | 171.0 | 31.4% | 130.1 | 556.1 |
| EBITDA | 26.4 | 28.1% | 20.6 | 82.1 |
| EBIT | 19.6 | 35.0% | 14.5 | 56.8 |
| Semperflex | ||||
| Revenue | 79.8 | 45.9% | 54.7 | 240.5 |
| EBITDA | 19.6 | 58.9% | 12.3 | 51.3 |
| EBIT | 16.6 | 73.9% | 9.6 | 40.0 |
| Sempertrans | ||||
| Revenue | 28.3 | 5.1% | 26.9 | 104.5 |
| EBITDA | 1.3 | 23.6% | 1.0 | 6.8 |
| EBIT | 0.3 | 75.3% | 0.2 | 3.2 |
| Semperform | ||||
| Revenue | 26.2 | 32.5% | 19.8 | 90.6 |
| EBITDA | 3.2 | 5.1% | 3.1 | 12.4 |
| EBIT | 2.1 | 0.4% | 2.1 | 8.5 |
| Semperseal | ||||
| Revenue | 36.6 | 27.5% | 28.7 | 120.5 |
| EBITDA | 2.4 | –43.8% | 4.2 | 11.6 |
| EBIT | 0.5 | –80.4% | 2.6 | 5.1 |
| Medical Sector = Sempermed | ||||
| Revenue | 106.1 | –45.0% | 192.9 | 626.1 |
| EBITDA | 13.3 | –87.3% | 105.3 | 301.1 |
| EBIT | 7.6 | –92.4% | 100.2 | 280.9 |
Note: Rounding differences in the totalling of rounded amounts and percentages may arise from the use of automatic data processing.
1 Earnings per share are only attributable to the core shareholders of Semperit AG Holding (excl. remuneration from hybrid capital).
2 Based on a full-year projection.
The publicly listed Semperit Group recorded decrease in earnings in Q1 2022 in comparison with the extraordinary positive results in Q1 2021. In the Industrial Sector the result for the same period in the previous year was clearly exceeded despite the difficult global market environment. In the Medical Sector, on the other hand, earnings declined as expected due to the fading of the exceptional boom resulting from the pandemic.
Over the course of Q1 2022, prices on the relevant Asian commodity exchanges for natural rubber (most relevant for Sempertrans) and natural latex (relevant for Sempermed) trended further higher compared with Q1 2021 (natural rubber +6% and natural latex +4%).
In Q1 2022, the average prices for the essential basic raw material butadiene (relevant for all segments) reached a significantly higher level in Asia (+12%) and Europe (+58%) than in Q1 2021. This, combined with a significant supply shortage in the face of sustained strong demand, led to a further sharp rise in the prices of butadiene derivatives, such as butadiene rubber, styrene butadiene rubber, and nitrile butadiene rubber.
Prices for nitrile latex, the most important raw material for Sempermed, continued to decline over the course of Q1 2022 despite increased prices for butadiene due to declining market demand.
The price trend of heavy fuel oil (HFO), which in turn correlates closely with the general trend in crude oil prices, is a relevant indicator for the filler carbon black, which is used in the entire Industrial Sector. The average HFO price was more than 50% higher from January to March than in Q1 2021. Due to this development and a tight supply situation as well as considerably higher energy and logistics costs, carbon black prices increased significantly compared with Q1 2021.
In Q1 2022, prices for wire rod – a raw material relevant for the Semperflex, Sempertrans, and Semperform segments – continued the rising trend that began in mid-2020. Whereas in the previous year it was assumed that the peak had been reached with the multi-year high, the world market has exhibited new highs as a result of the significant deterioration in the supply situation. The situation is even more drastic especially in Europe, where the sharp rise in transport and energy costs combined with high demand has meant that the level of last year's multi-year high has meanwhile more than doubled. The price of iron ore – the basic raw material for wire rod – has been rising again at a rapid rate since November 2021 following an adjustment from USD 220/t to USD 90/t and is currently USD 140/t.
In addition to raw material prices, general inflation and in particular sharply rising energy prices as well as increases in wages and salaries are becoming additional cost drivers.
On 24 February 2022, the Russia-Ukraine conflict reached a new level of escalation with Russia launching a war of aggression against Ukraine. Since the outbreak of this war, numerous international punitive sanctions have been imposed on Russia (and Belarus); stiffer sanctions continue to be discussed.
The Semperit Group's revenue from customers in the countries affected by the Russia-Ukraine conflict (Russia, Belarus, and Ukraine) comprised around 2% of total revenue in Q1 2022 (Q1 2021: 3%). The Semperit Group has stopped deliveries to customers in Russia and Belarus in the context of the EU sanctions.
A shift in global procurement flows and inventory management is to be noted for key raw materials and consumables used in the manufacture of vulcanised rubber products as a result of the Russia-Ukraine conflict. The Semperit Group has long since stepped up international multiple sourcing activities and increased reserves of production-critical materials, such as certain fillers. As a result, the inventory range is now several weeks longer than usually necessarry. Storage capacities along the supply chain are used for this purpose. Nevertheless, it cannot be ruled out that in future, in particular in the second half of 2022, material shortages will lead to production constraints at the European production sites and consequently to delivery delays and restrictions. Production sites outside of Europe, on the other hand, are not expected to be affected by these constraints.
Prices for synthetic rubber, paraffinic oils, and fillers such as soot and silicates correlate strongly with the market price trend for crude oil and natural gas due to the energy intensity of their production. Suppliers are dropping out as a result of the sanctions, whereby price-driving surplus demand can also be observed. In light of this, the Semperit Group again anticipates price increases – in some cases considerable – for key raw materials and consumables; price pass-through opportunities will depend on the price sensitivity of the respective customers and the dynamics on the segment-specific product markets. In addition, the Semperit Group continues to expect additional costs due to rising energy prices. In this context, it is to be noted that around 60% of the price risks for natural gas at the European production sites are partially hedged depending on actual demand. The non-European production sites are not affected by the price increases and volatility on the European gas market.
The Semperit Group's management is closely monitoring the geopolitical and market-related developments in connection with the Russia-Ukraine conflict and is taking a prudent approach to the situation. All employees of the Semperit Group who were travelling in Russia, Belarus, or Ukraine, particularly in the course of their sales activities, were promptly and safely brought back to countries not directly affected by the war. Management initiated the evaluation of appropriate proactive measures to mitigate these developments at an early stage and is continuously conducting detailed analyses; initial packages of measures were immediately implemented with success and are being continued depending on the situation.
| in EUR million | Q1 2022 | Change | Q1 2021 | 2021 |
|---|---|---|---|---|
| Revenue | 277.0 | –14.2% | 323.1 | 1,182.2 |
| EBITDA | 36.5 | –70.1% | 122.2 | 361.8 |
| EBITDA margin | 13.2% | –24.6 PP | 37.8% | 30.6% |
| EBIT | 23.7 | –78.6% | 110.8 | 315.0 |
| EBIT margin | 8.6% | –25.7 PP | 34.3% | 26.6% |
| Earnings after taxes | 15.5 | –81.8% | 85.5 | 247.5 |
| Additions to intangible assets and property, plant and equipment |
10.0 | –17.9% | 12.2 | 56.4 |
| Employees (at reporting date)1 | 7,007 | +0.1% | 7,001 | 6,948 |
The Semperit Group recorded a decrease in revenue in Q1 2022 of –14.2% to EUR 277.0 million compared with the previous year. Revenue in the Industrial Sector increased by 31.4% to EUR 171.0 million, whereas revenue in the Medical Sector decreased by –45.0% to EUR 106.1 million. The increase in revenue in the Industrial Sector was driven in particular by the rise in average selling prices in all segments (Semperflex +32.5%, Sempertrans +25.3%, Semperseal +25.1%, and Semperform +23.6%) compared with Q1 2021, whereby raw material and energy-related price increases were promptly passed on for the most part. This more than compensated for the decline in sales volumes observed in the Sempertrans segment in light of the overcrowded US ports and the associated delays together with partial shifts of deliveries to after the end of the quarter. At the same time, sales volumes increased, particularly in the Semperflex and Semperform segments. At Semperflex (+13.4%), this was due to a positive market environment as well as increases in the global market share of hydraulic and industrial hoses, while the increase in sales volumes in the Semperform segment (+8.9%) can be mainly attributed to the recovery of the busienss unit Special Applications – which primarily produces products related to the winter tourism industry. The expected decrease in revenue in the Medical Sector was due in particular to the declining price level. Although sales prices are still above pre-Corona levels, they continue to decline steadily compared with prior periods. Sales volumes increased slightly (5.3%) as a result of limited container availiability: while their situation is still tense, the circumstances have improved somewhat.
Picking up where it left off prior to the Corona crisis, the Industrial Sector generated 62% of the Semperit Group's revenue in Q1 2022 (Q1 2021: 40%), while the Medical Sector generated 38% (Q1 2021: 60%). Thus, the relationship between the sales volumes is now exactly the opposite of what it was during the same period in 2021.
The inventory of own products increased by EUR 3.3 million in Q1 2022 (Q1 2021: EUR 10.4 million), in particular as a consequence of the congestion at American ports – as a result of which container ships are increasingly becoming "floating warehouses" – as well as the significant increase in global transport times. This was offset by effects from inventory valuation in the Sempermed segment.
Other operating income decreased year over year by a total of EUR 1.1 million. In Q1 2021, this item included, among other things, a research grant in the amount of EUR 1 million, which has not yet been recognised this year.
The cost of materials (including energy and purchased services) increased by EUR 16.7 million or +12.2% to EUR 153.8 million in Q1 2022. The change was largely due to higher energy prices in both sectors, but also to the increased cost of materials in the Industrial Sector; lower production volumes at Sempermed had an opposite effect.
Personnel expenses increased to EUR 58.9 million (+11.2%) in Q1 2022. The main reasons for this were primarily general wage and salary increases and increased costs for additional temporary workers and production staff.
At EUR 33.0 million, other operating expenses were up around +37.6% year over year (Q1 2021: EUR 24.0 million). The increase can be attributed in particular to higher outbound freight expenses of around EUR 6.3 million and, to a lesser extent, to price-related increases in non-production-related energy costs.
As expected, EBITDA, which rose sharply in the past two years as a result of the special economic situation brought about by the Corona-pandemic, fell considerably from EUR 122.2 million in Q1 2021 to EUR 36.5 million in Q1 2022 – a decline of –70,1%. The EBITDA margin was 13.2% (Q1 2021: 37.8%).
Depreciation and amortisation increased to EUR 12.8 million (+12.5%) in Q1 2022; this can be attributed mainly to capital expenditures to of the glove plant in Kamunting, Malaysia ("Plant 7 plus, or P7+"), where six new production lines were ceremonially commissioned on 30 April 2022. EBIT decreased to EUR 23.7 million in Q1 2022 from EUR 110.8 million in the previous year. The Semperit Group's EBIT margin decreased from 34.3% in Q1 2021 to currently 8.6%.
The negative financial result shrank to EUR 2.5 million, representing a significant year-over-year improvement (Q1 2021: EUR 6.1 million). The other financial result increased by EUR 3.5 million, in particular due to a higher net foreign currency gain. In Q1 2021, the net foreign currency result was driven in particular by the US dollar exchange rate trend. In Q1 2022, net foreign currency result was influenced by the development of the Czech koruna, the Polish zloty, and the US dollar.
Tax expense decreased to in Q1 2022 to EUR 5.7 million (Q1 2021: EUR 19.3 million). The high tax expense in the previous year was due to the exceptional economic trend during the pandemic and the resulting increase in earnings in the Sempermed segment. In Q1 2022, the tax rate was 25.1% (Q1 2021: 18.4%).
Due to the expected lower operating result, earnings after tax amounted to EUR 15.5 million, down –81.8% from the previous year (Q1 2021: EUR 85.5 million). This was offset in particular by foreign exchange effects in the financial result, as well as a lower tax expense. The earnings per share attributable to the shareholders of Semperit AG Holding for Q1 2022 amounted to EUR 0.75 (Q1 2021: EUR 4.13).
A dividend of EUR 1.50 per share was resolved for the 2021 financial year at the Annual General Meeting held on 27 April 2022, which led to a total distribution of EUR 30.8 million. At a share price of EUR 29.30 at the end of 2021, this results in a dividend yield of 5.1%. A dividend of EUR 1.50 per share was also distributed in the previous year, which corresponded to a dividend yield of 6.2% based on the closing price of EUR 24.30 in 2020.
The development of the balance sheet structure as at 31 March 2022 can be summarised as follows:
| in EUR million | 31.03.2022 | Share | 31.12.2021 | Share | Change |
|---|---|---|---|---|---|
| Non-current assets | 407.1 | 41% | 407.4 | 43% | –0.1% |
| Current assets | 589.6 | 59% | 551.1 | 57% | +7.0% |
| ASSETS | 996.7 | 100% | 958.6 | 100% | +4.0% |
| Equity1 | 561.5 | 56% | 541.2 | 56% | +3.8% |
| Non-current provisions and liabilities |
142.9 | 14% | 140.1 | 15% | 2.0% |
| Current provisions and liabilities | 292.3 | 29% | 277.3 | 29% | +5.4% |
| EQUITY AND LIABILITIES | 996.7 | 100% | 958.6 | 100% | +4.0% |
1 including non-controlling interests
Current assets have increased since 31 December 2021, in particular due to an increase in trade receivables. In addition, the increase in current assets can be attributed to a EUR 16.2 million increase in inventories – in particular in the Sempertrans and Semperflex segments.
Equity increased due to the profits of the current period. The return on equity amounted to 11.1% (Q1 2021: 86.2%). The currency translation reserve was reduced predominantly due to changes in the exchange rates for the US dollar (USD), Czech crown (CZK), and Malaysian ringgit (MYR).
The increase in current liabilities resulted primarily from the increase in trade payables. A decrease in liabilities from current taxes had an offsetting effect. As of 31 March 2022, the Semperit Group exhibited a net cash surplus of EUR 144.0 million, as cash and cash equivalents exceeded financial liabilities (net cash surplus as of 31 December 2021: EUR 144.2 million). The calculated ratio between the net cash surplus (i.e. theoretical negative net indebtedness) and EBITDA as at 31 March 2022 was thus –0.5x (31 December 2021: –0.4x). In this context, the negative value of net debt and its ratio to EBITDA means that cash exceeds liabilities, resulting in negative calculated values.
The existing credit facilities with a bank consortium and Österreichische Kontrollbank AG (OeKB) amounting to EUR 75 million and EUR 15 million, respectively, have not yet been used.
The development of the liquidity situation in Q1 2022 can be summarised as follows:
| in EUR million | Q1 2022 | Change | Q1 2021 | 2021 |
|---|---|---|---|---|
| Cash flows from operating activities | 17.5 | –74.9% | 69.8 | 289.2 |
| Cash flows from investing activities | –17.7 | –43.0% | –31.0 | –48.0 |
| Free cash flow | –0.1 | >100% | 38.8 | 241.2 |
| Cash flows from financing activities | –6.2 | –80.6% | –32.1 | –155.6 |
| Net increase / decrease in cash and cash equivalents |
–6.3 | >100% | 6.8 | 85.6 |
| Cash and cash equivalents at the end of the period |
231.1 | +49.8% | 154.3 | 235.5 |
The cash flow from operating activities was down compared with Q1 2021 primarily due to the lower earnings but was also further reduced by EUR 27.1 million due to the increase in trade working capital.
Cash expenditures on intangible assets and property, plant and equipment amounted to EUR 17.2 million in Q1 2022, putting them above the previous year's level of EUR 10.2 million. The largest investments were made in Malaysia in the amount of EUR 6.6 million (Q1 2021: EUR 2.7 million), Austria in the amount of EUR 5.4 million (Q1 2021: EUR 2.9 million), the Czech Republic in the amount of EUR 1.5 million (Q1 2021: EUR 1.4 million), and Poland in the amount of EUR 1.2 million (Q1 2021: EUR 1.3 million).
In Q1 2022, free cash flow totalled EUR –0.1 million, compared with EUR 38.8 million in Q1 2021.
Cash flow from financing activities in Q1 2022 included the repayment of a current financial liability in Malaysia in the amount of EUR 4.8 million. In Q1 2021, this item included in particular the repayment of hybrid capital in the amount of EUR 30.0 million and the payment of hybrid coupons in the amount of EUR 0.8 million.
| in EUR million | Q1 2022 | Change | Q1 2021 | 2021 |
|---|---|---|---|---|
| Revenue | 171.0 | 31.4% | 130.1 | 556.1 |
| EBITDA | 26.4 | 28.1% | 20.6 | 82.1 |
| EBITDA margin | 15.5% | –0.4 PP | 15.9% | 14.8% |
| EBIT | 19.6 | 35.0% | 14.5 | 56.8 |
| EBIT margin | 11.5% | +0.3 PP | 11.2% | 10.2% |
| Additions to intangible assets and property, plant and equipment |
4.3 | –37.2% | 6.8 | 28.7 |
| Employees (at reporting date)1 | 3,881 | 9.1% | 3,557 | 3,764 |
1 The definition of the allocation key for overhead functions was adapted, resulting in slight shifts between the segments; the prior-year figures were adjusted accordingly.
In the Industrial Sector – comprising the Semperflex, Sempertrans, Semperseal, and Semperform segments – a sustained overall positive sales trend was observed in Q1 2022, although this varied in the individual segments. Following the above-average trend in H1 2021, a slight decrease in current demand and the associated incoming orders has been observed continuously since the second half of 2021. Nevertheless, the order books are still higher than they were in Q1 2021. At the same time, the continuous increases in raw material and energy prices, which were further exacerbated by the Russia-Ukraine war as well as rising wage levels, are putting pressure on margins. The ongoing effort to pass on price increases in the various input factors to customers in a timely manner should counteractagainst the pressure on margins resulting from these developments.
| in EUR million | Q1 2022 | Change | Q1 2021 | 2021 |
|---|---|---|---|---|
| Revenue | 79.8 | 45.9% | 54.7 | 240.5 |
| EBITDA | 19.6 | 58.9% | 12.3 | 51.3 |
| EBITDA margin | 24.5% | +2.0 PP | 22.5% | 21.3% |
| EBIT | 16.6 | 73.9% | 9.6 | 40.0 |
| EBIT margin | 20.8% | +3.4 PP | 17.5% | 16.6% |
| Additions to intangible assets and property, plant and equipment |
1.1 | 54.9% | 0.7 | 8.0 |
| Employees (at reporting date)1 | 1,834 | 12.8% | 1,626 | 1,753 |
1 The definition of the allocation key for overhead functions was adapted, resulting in slight shifts between the segments; the prior-year figures were adjusted accordingly.
Already Q1 2021 was characterized by a market recovery following the slump due to the pandemic. This positive sentiment has persisted, although a gradual cooling has been evident since H2 2021. Semperflex customers nevertheless continued to exhibit above-average demand in Q1 2022. This applies to hydraulic hoses as well as to industrial hoses. At the same time, the order books remained at an above-average level – even compared with their level prior to the onset of Corona.
Revenue was up significantly as a result of the increased sales volumes brought about by growing demand, supported by the expansion of production volumes in Odry as well as the price increases necessitated by rising costs for raw materials and logistics expenses. The negative effects of the dramatically elevated and further rising raw material, container, and energy prices, which were further boosted by the war between Russia and Ukraine, placed a burden on earnings. However, just as with the wage increases and the tight availability of raw materials and containers, these effects were offset by considerable increases in sales volumes and the resulting volume advantages, efficiency gains, and price increases. Consequently, EBITDA and EBIT as well as the corresponding margins in Q1 2022 exceeded the respective levels in Q1 2021.
| in EUR million | Q1 2022 | Change | Q1 2021 | 2021 |
|---|---|---|---|---|
| Revenue | 28.3 | 5.1% | 26.9 | 104.5 |
| EBITDA | 1.3 | 23.6% | 1.0 | 6.8 |
| EBITDA margin | 4.5% | +0.7 PP | 3.8% | 6.6% |
| EBIT | 0.3 | 75.3% | 0.2 | 3.2 |
| EBIT margin | 1.2% | +0.5 PP | 0.7% | 3.1% |
| Additions to intangible assets and property, plant and equipment |
0.3 | –37.3% | 0.5 | 4.1 |
| Employees (at reporting date)1 | 874 | –4.8% | 918 | 921 |
1 The definition of the allocation key for overhead functions was adapted, resulting in slight shifts between the segments; the prior-year figures were adjusted accordingly
As expected, the late-cycle business in the Sempertrans segment was able to realize the first positive results from the favourable development of the project pipelines in Q1 2022. Demand for conveyor and transport belts also increased, driven by the price trend for mining products, which was favourable for Sempertrans' order situation, and global demand in 2021. This general trend has so far remained unaffected by the Russia-Ukraine war; demand in particular for large-scale replacement projects is strong. The positive sentiment is reflected in an order book level that is more than 100% above the level at the end of Q1 2021.
As a result, the first slight increase in sales was recorded in Q1 2022. Although in view of the overcrowded US ports deliveries were partially delayed to after the end of the quarter, sales-side price increases in the wake of sharp cost increases have made a positive contribution to the development of revenue. Despite rising input factor prices also driven by the Russia-Ukraine war, an increase in EBITDA and EBIT as well as in the corresponding margins was also recorded. At the same time, impending material shortages proved to be manageable and negative effects on production were avoided.
| in EUR million | Q1 2022 | Change | Q1 2021 | 2021 |
|---|---|---|---|---|
| Revenue | 36.6 | 27.5% | 28.7 | 120.5 |
| EBITDA | 2.4 | –43.8% | 4.2 | 11.6 |
| EBITDA margin | 6.5% | –8.2 PP | 14.7% | 9.6% |
| EBIT | 0.5 | –80.4% | 2.6 | 5.1 |
| EBIT margin | 1.4% | –7.8 PP | 9.2% | 4.2% |
| Additions to intangible assets and property, plant and equipment |
1.8 | –62.7% | 4.9 | 11.5 |
| Employees (at reporting date)1 | 567 | 22.0% | 465 | 514 |
1 The definition of the allocation key for overhead functions was adapted, resulting in slight shifts between the segments; the prior-year figures were adjusted accordingly.
The markets posted a further slight improvement in Q1 2022 following a solid recovery in the 2021 financial year, with the order book volume as of the end of the Q1 2022 reporting period significantly higher than the volume in Q1 2021. The Russia-Ukraine crisis had already started to have a slight impact by the end of Q1 2022. The fact that the Semperit Group has terminated its business activities with Russian customers will be reflected in the further development of the order book.
A noticeable increase in revenue was achieved as a consequence of high demand for products from the business unit Profiles and the gradual implementation of price increases. At the same time, however, rising input factor prices put pressure on EBITDA and EBIT development, as the increases could only be passed on with a time lag and not to the full extent. As a result, EBITDA, EBIT, and the corresponding margins were well below the level of Q1 2021.
Production at the new rubber gasket plant in the USA (Newnan, Georgia) commenced in Q1 2022. The first deliveries were already carried out in April; work is currently underway to ramp up an additional production line.
Key figures Semperform
| in EUR million | Q1 2022 | Change | Q1 2021 | 2021 |
|---|---|---|---|---|
| Revenue | 26.2 | 32.5% | 19.8 | 90.6 |
| EBITDA | 3.2 | 5.1% | 3.1 | 12.4 |
| EBITDA margin | 12.2% | –3.2 PP | 15.4% | 13.7% |
| EBIT | 2.1 | 0.4% | 2.1 | 8.5 |
| EBIT margin | 8.2% | –2.6 PP | 10.8% | 9.4% |
| Additions to intangible assets and property, plant and equipment |
1.1 | 44.0% | 0.8 | 5.2 |
| Employees (at reporting date)1 | 605 | 10.6% | 548 | 576 |
1 The definition of the allocation key for overhead functions was adapted, resulting in slight shifts between the segments; the prior-year figures were adjusted accordingly.
The Semperform segment presented a comparatively improved picture with regard to the development of the individual business units in Q1 2022. The winter tourism industry in particular was able to gradually recover and showed increased demand for replacement products, in particular cable car rings. Healthy demand was observed in the handrail business. The niche markets of the Engineered Solutions unit, in particular railway and households, also showed increased activity. Thanks to these developments, order intake developed positively in Q1 2022; order book volume at the end of Q1 2022 exceeded the volume at the end of Q1 2021 by a considerable margin. The Russia-Ukraine crisis has not had any noticeable impact on business performance to date.
Revenue exceeded the level of Q1 2021 thanks in particular to the Special Applications and Engineered Solutions business units. At the same time, the sharp rise in input factor prices, despite price increases to compensate for these developments, had a negative impact on EBITDA and EBIT margins – although EBITDA and EBIT exceeded the comparative figures in absolute terms.
| in EUR million | Q1 2022 | Change | Q1 2021 | 2021 |
|---|---|---|---|---|
| Revenue | 106.1 | –45.0% | 192.9 | 626.1 |
| EBITDA | 13.3 | –87.3% | 105.3 | 301.1 |
| EBITDA margin | 12.6% | –42.0 PP | 54.6% | 48.1% |
| EBIT | 7.6 | –92.4% | 100.2 | 280.9 |
| EBIT margin | 7.2% | –44.8 PP | 52.0% | 44.9% |
| Additions to intangible assets and property, plant and equipment |
4.5 | –11.2% | 5.1 | 24.9 |
| Employees (at reporting date)1 | 3,052 | –7.7% | 3,307 | 3,038 |
1 The definition of the allocation key for overhead functions was adapted, resulting in slight shifts between the segments; the prior-year figures were adjusted accordingly.
The market development of the Sempermed segment in Q1 2022 was affected by two main factors compared with the same period of the previous year. On the one hand, Q1 2021 was still characterized by the marked increase in selling prices before a plateau was reached in Q2 2021. At the same time, Q1 2022 saw a continuation of the price reduction that has been ongoing since H2 2021. As a result, prices at the end of the quarter were still above pre-Corona levels. On the other hand, sales volumes of examination gloves increased, which partly compensated for the negative price effect. This was induced by the development of container availability, as – while its availability is still limited – the situation has sligtly improved in comparison with Q1 2021. However, longer transport times due to global logistics bottlenecks as well as high raw material and container prices continued to impact earnings.
This development as a result of the changed market environment is reflected in the key figures (revenue, EBITDA, EBIT, and margins). Despite the negative effects, however, it was possible – supported by high efficiency – to achieve a margin level that remains above the pre-Corona level.
The new "Plant 7 plus" production facilities were fully completed and formally opened shortly after the end of Q1 2022.
The headcount of 7,007 employees (FTE, full-time equivalents) as of 31 March 2022 was only slightly higher (+0.1%) than the level on 31 March 2021 (7,001 employees). In the Industrial Sector, the number of employees increased in all segments compared with 31 March 2021, with the exception of Sempertrans. The workforce increased in particular in the Semperflex, Semperform, and Semperseal segments (12.8%, 10.6%, and 22.0% respectively), whereas the number of employees in the Sempertrans segment decreased by 4.8%. The number of employees in the Medical Sector fell by 7.7% year over year as a consequence of an increase in the level of operational efficiency and automation. The definition of the allocation key for overhead functions was adapted, resulting in slight shifts between the segments; the prior-year figures were adjusted accordingly.
The Supervisory Board appointed Dr. Karl Haider as the new CEO of Semperit AG Holding at the beginning of January 2022. He began working on 11 January 2022, and his term of office runs until 31 March 2025.
At the 133rd Annual General Meeting on 27 April 2022, the number of members on the Supervisory Board was reduced within the limits specified in the Articles of Association from eight to a total of seven members elected by the Annual General Meeting. Herbert Ortner was re-elected to the Supervisory Board at the Annual General Meeting following the end of his term of office. Stephan Büttner was elected as a new member of the Supervisory Board.
Following the special economic cycle as a result of the pandemic and the high demand for medical products in 2021, price levels are now expected to normalize in the course of the 2022 financial year. However, it is still difficult to forecast the effects in connection with the further development of the Corona pandemic, particularly due to the widely varying regional trends and their influence on the international production sites. This is currently evident, for example, in the recent developments in China. The results of the Semperit Group will continue to depend heavily on the availability and prices of the requisite raw materials, the supply chain, energy price trends, the sufficient availability of containers to be used to deliver its products, and the availability of qualified staff.
The Russia-Ukraine conflict developed into a new economic and geopolitical threat beginning in late February 2022 with the start of a Russian war of aggression against Ukraine. The already observable consequences of this armed conflict include – to a limited extent – direct and indirect negative influences on the Semperit Group's sales volume and revenue figures, impending material bottlenecks, energy and raw material price increases, transport and supply chain problems, changes in the interest rate landscape, increased inflation expectations, and an increased risk of cyberattacks on companies. Material shortages of key raw materials and consumables for the manufacture of vulcanised polymer products could lead to production constraints in 2022, in particular during the second half of the year, and consequently to delivery delays and restrictions. With respect to expenses, additional costs are expected for raw materials and consumables, input and intermediate products, and energy and transportation expenses. In addition, the current situation will have a noticeable cost-increasing effect on wages and salaries. Price pass-through opportunities will depend on the price sensitivity of the respective customers and the dynamics in the segment-specific product markets. With respect to interest rate exposure, the Semperit Group is protected against changes in interest rates, as all outstanding promissory note loans bear interest at a fixed rate. The Semperit Group's management is acting prudently and has initiated the evaluation of appropriate proactive measures to mitigate these developments at an early stage; packages of measures, particularly in the area of materials management, have been successfully implemented since the first days of the war. Current geopolitical and market developments in connection with the Russia-Ukraine war are being closely monitored, as are their effects on capital goods markets and the market for business acquisitions.
Against the backdrop of an expected subsiding course of the Corona pandemic with declining average sales prices for medical products and impending material bottlenecks, supply chain issues, and sharp increases in input factor prices in industrial production, management expects another year characterised by major challenges for the Semperit Group's transformation process. Market dynamics should be expected to negatively impact the Semperit Group and/or individual segments. Despite the very positive first quarter, the management of the Semperit Group expects that the annual result for 2022 is likely to fall significantly short of the average market expectations, which were still EUR 100–120 million at the beginning of March 2022, in particular due to the Russia-Ukraine war and the related sanctions and uncertainties for industrial production. This is primarily due to the anticipated negative effects in the second half of the year, measured in terms of earnings before interest, tax, depreciation and amortisation (EBITDA). The exact financial impact on the expected annual result of the Semperit Group cannot yet be estimated at the time of publication of the interim report for Q1 2022.
At the end of January 2020, the Semperit Group announced its goal of transforming the company into an industrial polymer specialist as part of a strategic realignment. Although this step had been delayed by the coronavirus pandemic, the newly formed Semperit Group Executive Board will continue to consistently pursue the planned transformation process in the 2022 financial year. Measures to increase profitability are still high on the Executive Board's list of priorities. Strategic corporate development projects have the clear objective of inorganic and organic growth.
Investments aimed at growth and a dividend strategy designed to match are and were made possible in particular by the earnings realised by the Sempermed segment as a result of the special economic developments during the 2020 and 2021 financial years .
This outlook is based on the assessments of the Executive Board as of 17 May 2022 and does not take into account the impact of potential acquisitions, divestments, or other unforeseeable structural and economic changes during the remainder of 2022. These assessments are subject to both known and unknown risks and uncertainties, which may result in actual events and outcomes differing from the statements made here.
| in EUR thousand | Note | Q1 2022 | Q1 2021 |
|---|---|---|---|
| Revenue | 2.2 | 277,036 | 323,062 |
| Changes in inventories | 3,313 | 10,404 | |
| Own work capitalised | 991 | 833 | |
| Operating revenue | 281,340 | 334,299 | |
| Other operating income | 2.3 | 864 | 1,954 |
| Cost of material and purchased services | –153,757 | –137,033 | |
| Personnel expenses | –58,922 | –53,009 | |
| Other operating expenses | 2.4 | –32,995 | –23,987 |
| Earnings before interest, tax, depreciation and amortisation (EBITDA) | 36,531 | 122,224 | |
| Depreciation and amortisation of intangible assets and property, plant and equipment | –12,829 | –11,403 | |
| Earnings before interest and tax (EBIT) | 23,702 | 110,821 | |
| Finance income | 91 | 78 | |
| Finance expenses | –760 | –972 | |
| Profit / loss attributable to redeemable non-controlling interests | –1,333 | –1,146 | |
| Other financial result | 2.5 | –505 | –4,027 |
| Financial result | –2,506 | –6,067 | |
| Earnings before taxes | 21,196 | 104,753 | |
| Income taxes | –5,657 | –19,280 | |
| Earnings after taxes | 15,538 | 85,473 | |
| thereof attributable to the shareholders of Semperit AG Holding – from ordinary shares | 15,494 | 84,943 | |
| thereof attributable to the shareholders of Semperit AG Holding – from hybrid capital | 0 | 388 | |
| thereof attributable to non-controlling interests | 45 | 142 | |
| Earnings per share in EUR (diluted and undiluted)1 | 0.75 | 4.13 |
1The earnings per share are solely attributable to the ordinary shareholders of Semperit AG Holding (excl. interest from hybrid capital).
| in EUR thousand | Note | Q1 2022 | Q1 2021 |
|---|---|---|---|
| Earnings after taxes | 15,538 | 85,473 | |
| Other comprehensive income that will not be recognised through profit and loss in future periods |
–286 | –97 | |
| Remeasurements of defined benefit plans | 0 | 0 | |
| Income tax thereon | –286 | –97 | |
| Other comprehensive income that will be recognised through profit and loss in future periods |
5,124 | 9,430 | |
| Measurement gain or loss from cash flow hedges | 0 | 0 | |
| thereof reclassification to profit / loss for the period | 0 | 481 | |
| Currency translation differences | 5,124 | 9,430 | |
| Other comprehensive income - total | 4,838 | 9,334 | |
| Comprehensive income | 20,376 | 94,807 | |
| thereof on earnings attributable to the shareholders of Semperit AG Holding – from ordinary shares |
20,320 | 94,242 | |
| thereof attributable to the shareholders of Semperit AG Holding – from hybrid capital | 0 | 388 | |
| thereof on earnings attributable to non-controlling interests | 56 | 177 |
| in EUR thousand | Note | Q1 2022 | Q1 2021 |
|---|---|---|---|
| Earnings before taxes | 21,196 | 104,753 | |
| Depreciation, amortisation, impairment and reversal of impairment of intangible assets and property, plant and equipment |
12,829 | 11,403 | |
| Gain / loss from disposal of assets (including current and non-current financial assets) |
–39 | –51 | |
| Change in non-current provisions | 467 | –690 | |
| Profit / loss attributable to redeemable non-controlling interests | 1,333 | 1,146 | |
| Net interest income (including income from securities) | 666 | 894 | |
| Income taxes paid | –11,614 | –2,141 | |
| Other non-cash income / expense | 4,802 | 3,372 | |
| Gross cash flow | 29,640 | 118,687 | |
| Change in inventories | –18,732 | –27,941 | |
| Change in trade receivables | –32,660 | –31,439 | |
| Change in other receivables and assets | 9,417 | 514 | |
| Change in trade payables | 24,131 | 4,965 | |
| Change in other liabilities and current provisions | 5,752 | 5,064 | |
| Cash flows from operating activities | 17,547 | 69,849 | |
| Proceeds from sale of property, plant and equipment | 72 | 103 | |
| Purchases of intangible assets and property, plant and equipment | –17,170 | –10,156 | |
| Interest received | 85 | 85 | |
| Investment grants received | 37 | 18 | |
| Acquisition of financial assets | –711 | –19,959 | |
| Acquisition of a subsidiary, net of cash acquired | 0 | –1,126 | |
| Cash flows from investing activities | –17,687 | –31,034 | |
| Repayment of current and non-current financial liabilities | –4,825 | –11 | |
| Repayment of lease liabilities | –771 | –816 | |
| Dividends to redeemable non-controlling interests in subsidiaries | 0 | –123 | |
| Capital repayment to non-controlling interests in subsidiaries | –343 | 0 | |
| Repayment of hybrid capital | 0 | –30,000 | |
| Coupon payments on hybrid capital | 0 | –785 | |
| Interest paid | –268 | –328 | |
| Cash flows from financing activities | –6,206 | –32,063 | |
| Net increase / decrease in cash and cash equivalents | –6,346 | 6,752 | |
| Currency translation differences | 1,910 | 2,560 | |
| Cash and cash equivalents at the beginning of the period | 235,539 | 144,972 | |
| Cash and cash equivalents at the end of the period | 231,103 | 154,285 |
| ASSETS Non-current assets Intangible assets 8,112 8,492 Property, plant and equipment 377,619 376,576 Other financial assets 6,486 7,430 Other assets 3,893 3,241 Deferred tax assets 10,978 11,707 407,089 407,447 Current assets Inventories 203,066 186,834 Trade receivables 132,637 98,766 Other financial assets 2,755 1,536 Other assets 14,944 23,625 Current tax receivables 4,369 4,064 Cash and cash equivalents 231,103 235,539 588,873 550,365 Non-current assets held for sale 764 764 589,637 551,128 ASSETS 996,726 958,575 EQUITY AND LIABILITIES Equity Share capital 21,359 21,359 Capital reserves 21,503 21,503 Retained earnings 527,424 512,216 Currency translation reserve –9,844 –14,956 Equity attributable to the shareholders of Semperit AG Holding 560,443 540,122 Non-controlling interests 1,084 1,028 561,527 541,151 Non-current provisions and liabilities Provisions 43,831 42,824 Liabilities from redeemable non-controlling interests 13,519 11,941 Financial liabilities 51,829 51,685 Trade payables 151 154 Other financial liabilities 19,409 19,602 Other liabilities 1,926 1,948 Deferred tax assets 12,235 11,954 142,899 140,108 Current provisions and liabilities Provisions 28,600 26,406 Liabilities from redeemable non-controlling interests 5,708 5,595 Financial liabilities 35,319 39,654 Trade payables 113,540 95,166 Other financial liabilities 16,276 12,826 Other liabilities 41,207 40,844 Current tax liabilities 51,649 56,826 292,300 277,317 EQUITY AND LIABILITIES 996,726 958,575 |
in EUR thousand | Note | 31.03.2022 | 31.12.2021 |
|---|---|---|---|---|
| in EUR thousand | Note | Share capital |
Capital reserves |
Hybrid capital |
Retained earnings |
Currency translation reserve |
Total | Non controlling interests |
Total equity |
|---|---|---|---|---|---|---|---|---|---|
| As at 01.01.2021 | 21,359 | 21,503 | 30,000 | 294,886 | –35,483 | 332,266 | 2,331 | 334,597 | |
| Earnings after taxes | 0 | 0 | 0 | 85,331 | 0 | 85,331 | 142 | 85,473 | |
| Other comprehensive income |
0 | 0 | 0 | –97 | 9,395 | 9,299 | 35 | 9,334 | |
| Comprehensive income | 0 | 0 | 0 | 85,235 | 9,395 | 94,629 | 177 | 94,806 | |
| Dividend | 0 | 0 | 0 | 0 | 0 | 0 | –123 | –123 | |
| Coupon payments on hybrid capital |
0 | 0 | 0 | –785 | 0 | –785 | 0 | –785 | |
| Repayment of hybrid capital |
0 | 0 | –30,000 | 0 | 0 | –30,000 | 0 | –30,000 | |
| As at 31.03.2021 | 21,359 | 21,503 | 0 | 379,335 | –26,087 | 396,109 | 2,385 | 398,496 | |
| As at 01.01.2022 | 21,359 | 21,503 | 0 | 512,216 | –14,956 | 540,122 | 1,028 | 541,151 | |
| Earnings after taxes | 0 | 0 | 0 | 15,494 | 0 | 15,494 | 45 | 15,538 | |
| Other comprehensive income |
0 | 0 | 0 | –286 | 5,113 | 4,827 | 11 | 4,838 | |
| Comprehensive income | 0 | 0 | 0 | 15,208 | 5,113 | 20,320 | 56 | 20,376 | |
| As at 31.03.2022 | 21,359 | 21,503 | 0 | 527,424 | –9,844 | 560,443 | 1,084 | 561,527 |
The interim group financial report has been prepared in accordance with International Financial Reporting Standards (IFRSs) and is based on the regulations for interim financial statements (IAS 34).
For more information on accounting and valuation methods of the Semperit-Group, please see the consolidated financial statements as at 31 December 2021, which in this regard form the basis for this interim group financial report.
The reporting currency is the euro, with figures rounded to the nearest thousand, unless expressly stated otherwise. Rounding differences in the totalling of rounded amounts and percentages may arise from the automatic processing of data.
The interim group financial report of the Semperit-Group as at 31 March 2022 have not been fully audited or reviewed by the Group's auditor.
The following amended standards and interpretations were applicable for the first time in the first quarter of 2022:
| Endorsement | Mandatory application for the Semperit-Group |
Effects on the Semperit-Group |
||
|---|---|---|---|---|
| Amended standards | ||||
| Miscellaneous | Amendments to IFRS 3, IAS 16 and IAS 37 | 28 June 2021 | 1 January 2022 | no |
| Miscellaneous | Annual improvements to IFRS, cycle 2018–2020 | 28 June 2021 | 1 January 2022 | no |
| Q1 2022 in EUR thousand | Semper med |
Semper flex |
Semper trans |
Semper seal |
Semper form |
Corporate Center |
Total |
|---|---|---|---|---|---|---|---|
| Revenue | 106,061 | 79,814 | 28,307 | 36,628 | 26,226 | 0 | 277,036 |
| EBITDA | 13,327 | 19,589 | 1,273 | 2,374 | 3,210 | –3,244 | 36,531 |
| EBIT | 7,600 | 16,635 | 334 | 519 | 2,148 | –3,534 | 23,702 |
| Trade working capital | 78,782 | 75,527 | 25,098 | 25,060 | 22,006 | –4,310 | 222,163 |
| Additions to intangible assets and property, plant and equipment1 |
4,492 | 1,054 | 344 | 1,813 | 1,088 | 1,206 | 9,997 |
| Q1 2021 in EUR thousand | Semper med |
Semper flex |
Semper trans |
Semper seal |
Semper form |
Corporate Center |
Total |
|---|---|---|---|---|---|---|---|
| Revenue | 192,918 | 54,697 | 26,929 | 28,718 | 19,800 | 0 | 323,062 |
| EBITDA | 105,259 | 12,331 | 1,030 | 4,223 | 3,055 | –3,676 | 122,224 |
| EBIT | 100,247 | 9,564 | 190 | 2,646 | 2,140 | –3,967 | 110,821 |
| Trade working capital | 122,439 | 51,093 | 20,501 | 17,143 | 16,638 | –2,409 | 225,404 |
| Additions to intangible assets and property, plant and equipment1 |
5,060 | 680 | 549 | 4,861 | 755 | 266 | 12,171 |
1Exclusive rights of use in accordance with IFRS 16.
| Q1 2022 in EUR thousand | Semper med |
Semper flex |
Semper trans |
Semper seal |
Semper form |
Group |
|---|---|---|---|---|---|---|
| Western Europe | 52,361 | 47,101 | 12,841 | 29,296 | 16,466 | 158,064 |
| North America | 26,512 | 9,271 | 2,382 | 2,337 | 1,244 | 41,746 |
| Eastern Europe | 14,438 | 15,695 | 3,390 | 4,847 | 3,110 | 41,480 |
| Asia | 6,947 | 5,781 | 5,800 | 145 | 4,964 | 23,636 |
| Central and South America | 4,576 | 1,243 | 582 | 3 | 384 | 6,789 |
| Australia and Oceania | 867 | 190 | 1,723 | 0 | 12 | 2,793 |
| Africa | 361 | 533 | 1,589 | 0 | 45 | 2,528 |
| Revenue | 106,061 | 79,814 | 28,307 | 36,628 | 26,226 | 277,036 |
| Q1 2021 in EUR thousand | Semper med |
Semper flex |
Semper trans |
Semper seal |
Semper form |
Group |
|---|---|---|---|---|---|---|
| Western Europe | 92,399 | 30,524 | 8,467 | 23,266 | 11,124 | 165,780 |
| North America | 50,008 | 4,462 | 723 | 1,312 | 1,083 | 57,588 |
| Eastern Europe | 22,342 | 12,100 | 5,871 | 3,888 | 2,408 | 46,609 |
| Asia | 21,359 | 6,858 | 6,719 | 246 | 4,746 | 39,928 |
| Central and South America | 4,307 | 440 | 606 | 6 | 302 | 5,660 |
| Australia and Oceania | 1,538 | 60 | 2,355 | 0 | 24 | 3,976 |
| Africa | 966 | 253 | 2,189 | 0 | 114 | 3,522 |
| Revenue | 192,918 | 54,697 | 26,929 | 28,718 | 19,800 | 323,062 |
Other operating income includes government grants in the amount of EUR 325 thousand (Q1 2021: EUR 262 thousand) that the Semperit-Group received in the form of pandemic-related support payments for the first quarter of 2022. The grants were granted in China and Austria.
| Outgoing freight Legal, consulting and auditing fees Maintenance and external services Insurance premiums Software licence expenses Energy costs unrelated to production Rental and lease expenses Commission and advertising expenses Travel expenses Other taxes Waste disposal Office equipment |
14,763 2,988 2,382 1,548 1,375 1,341 1,025 |
8,441 2,473 2,960 1,260 924 585 |
|---|---|---|
| 549 | ||
| 792 | 913 | |
| 683 | 247 | |
| 601 | 660 | |
| 564 | 635 | |
| 356 | 274 | |
| Fees, subscriptions and donations | 347 | 298 |
| Communications | 243 | 234 |
| Complaint costs | 194 | –294 |
| Training and education expenses | 160 | 87 |
| Bank expenses and hedging costs | 110 | 147 |
| Valuation allowances | 69 | 63 |
| Miscellaneous | 3,454 | 3,532 |
| Total | 32,995 | 23,987 |
| in EUR thousand | Q1 2022 | Q1 2021 |
|---|---|---|
| Expense (+) / income (–) | ||
| Other financial result | ||
| Net foreign currency result | 81 | 4,446 |
| Net result from the FVPL and FV measurement categories - hedging instruments | 339 | –549 |
| Miscellaneous | 84 | 130 |
| Total | 505 | 4,027 |
Am Belvedere 10 1100 Vienna, Austria Tel.: +43 1 79 777 0 Fax: +43 1 79 777 600 www.semperitgroup.com/en
Judit Helenyi Director Investor Relations Tel.: +43 1 79 777 310 www.semperitgroup.com/en/ir
www.semperitgroup.com/en/contact
Ownership and publisher: Semperit Aktiengesellschaft Holding, Am Belvedere 10, 1100 Vienna, Austria, Produced in-house with firesys GmbH, www.firesys.de
The terms "Semperit" or "Semperit Group" in this report refer to the group; "Semperit AG Holding" or "Semperit Aktiengesellschaft Holding" is used to refer to the parent company (individual company).
We have prepared this report and verified the information it contains with the greatest possible care. Nevertheless, rounding, typesetting and printing errors cannot be ruled out. Rounding of differences in the summation rounded amounts and percentages may arise from the automatic processing of data.
The forecasts, plans and forward-looking statements contained in this report are based on the knowledge and information available and the assessments made at the time that this report was prepared (editorial deadline: 17 May 2022). As is true of all forward-looking statements, these statements are subject to risk and uncertainties. As a result, actual events may deviate significantly from these expectations. No liability whatsoever is assumed for the accuracy of projections or for the achievement of planned targets or for any other forward-looking statements. Words such as "expect," "want", "believe," "anticipate," "includes," "plan," "assumes," "estimate," "projects," "intends," "should," "will," "shall," or variations of such words are generally part of forward-looking statements.
Furthermore, there is no guarantee that the contents are complete.
Statements referring to people are valid for both men and women.
This report has been written in German and English. In case of doubt, the German version shall take precedence.
| Financial Calendar 2022 | |
|---|---|
| 18.5.2022 | Report on Q1 2022 |
| 17.8.2022 | Half-year financial report 2022 |
| 16.11.2022 | Report on Q1-3 2022 |
WWW.SEMPERITGROUP.COM
Have a question? We'll get back to you promptly.